Whitehawk Therapeutics Statistics
Total Valuation
WHWK has a market cap or net worth of $237.72 million. The enterprise value is $114.68 million.
| Market Cap | 237.72M |
| Enterprise Value | 114.68M |
Important Dates
The next estimated earnings date is Thursday, August 6, 2026, before market open.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
WHWK has 53.78 million shares outstanding. The number of shares has increased by 128.91% in one year.
| Current Share Class | 53.78M |
| Shares Outstanding | 53.78M |
| Shares Change (YoY) | +128.91% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 9.38% |
| Owned by Institutions (%) | 23.59% |
| Float | 22.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.80 |
| P/TBV Ratio | 2.05 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.36
| Current Ratio | 11.36 |
| Quick Ratio | 11.13 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -68.54% and return on invested capital (ROIC) is -45.39%.
| Return on Equity (ROE) | -68.54% |
| Return on Assets (ROA) | -42.46% |
| Return on Invested Capital (ROIC) | -45.39% |
| Return on Capital Employed (ROCE) | -105.62% |
| Weighted Average Cost of Capital (WACC) | 8.48% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.99M |
| Employee Count | 29 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +119.90% in the last 52 weeks. The beta is 0.77, so WHWK's price volatility has been lower than the market average.
| Beta (5Y) | 0.77 |
| 52-Week Price Change | +119.90% |
| 50-Day Moving Average | 4.20 |
| 200-Day Moving Average | 3.02 |
| Relative Strength Index (RSI) | 54.62 |
| Average Volume (20 Days) | 312,257 |
Short Selling Information
The latest short interest is 843,660, so 1.57% of the outstanding shares have been sold short.
| Short Interest | 843,660 |
| Short Previous Month | 854,980 |
| Short % of Shares Out | 1.57% |
| Short % of Float | 3.77% |
| Short Ratio (days to cover) | 1.80 |
Income Statement
| Revenue | n/a |
| Gross Profit | -99.41M |
| Operating Income | -122.70M |
| Pretax Income | -115.81M |
| Net Income | -115.81M |
| EBITDA | -122.68M |
| EBIT | -122.70M |
| Earnings Per Share (EPS) | -$1.67 |
Balance Sheet
The company has $123.04 million in cash and n/a in debt, with a net cash position of $123.04 million or $2.29 per share.
| Cash & Cash Equivalents | 123.04M |
| Total Debt | n/a |
| Net Cash | 123.04M |
| Net Cash Per Share | $2.29 |
| Equity (Book Value) | 116.18M |
| Book Value Per Share | 2.46 |
| Working Capital | 114.49M |
Cash Flow
In the last 12 months, operating cash flow was -$107.78 million and capital expenditures -$1,000, giving a free cash flow of -$107.78 million.
| Operating Cash Flow | -107.78M |
| Capital Expenditures | -1,000 |
| Depreciation & Amortization | 23,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -107.78M |
| FCF Per Share | -$2.00 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
WHWK does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -128.91% |
| Shareholder Yield | -128.91% |
| Earnings Yield | -48.71% |
| FCF Yield | -45.34% |
Analyst Forecast
The average price target for WHWK is $6.50, which is 47.06% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.50 |
| Price Target Difference | 47.06% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
WHWK has an Altman Z-Score of -0.5 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.5 |
| Piotroski F-Score | 1 |